Health Condition 1: null- Women with complaints of abnormal vaginal discharge suggestive of bacterial vaginosis
Conditions
Interventions
Intervention1: Tab metronidazole and Probiotic capsule containig more than one million bacilli each of Lactobacillus Rhamnosus GR-I and Lactobacillus Reuteri RC-14: Tab metronidazole 500 mg 1-1-1 for
Sponsors
Dr Rukshana Shamshu
Eligibility
Inclusion criteria
Inclusion criteria: Women between 18 and 45 years attending gynaecology OPD with complaint vaginal discharge and/or vaginal itching who gives informed consent.
Exclusion criteria
Exclusion criteria: 1. Women of below 18 years and above 45 years age group. 2. Women with history of diabetes mellitus. 3. Women with malignancy or those on cancer chemotherapy. 4. Women with chroic liver disease,chroic renal disease. 5. Women with HIV infection and those on immunosuppressive therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess the effectiveness of the probiotic strains having Lactobacillus rhamnosus GR -1 and Lactobacillus reuteri RC-14 in the management of lower genital infections(bacterial vaginosis as an integral therapy with antibiotics.Timepoint: one year | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess the effectiveness of probiotics in maintaining a healthy genital flora throughout the treatment periodTimepoint: one year | — |
Countries
India
Contacts
Public ContactDr Jayasree Vaman
Outcome results
None listed